Gene · 57721
Papers4,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,298
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PIWI-interacting RNA-17458 is oncogenic and a potential therapeutic target in cervical cancer. | J Cancer | 2023 | 37325054 | PubTator, text mining | PubMed |
| PARP-dependent and NAT10-independent acetylation of N4-cytidine in RNA appears in UV-damaged chromatin. | Epigenetics Chromatin | 2023 | 37322549 | PubTator, text mining | PubMed |
| Cross-talk of RNA modification "writers" describes tumor stemness and microenvironment and guides personalized immunotherapy for gastric cancer. | Aging (Albany NY) | 2023 | 37319315 | PubTator, text mining | PubMed |
| Splicing factor TRA2A contributes to esophageal cancer progression via a noncanonical role in lncRNA m6 A methylation. | Cancer Sci | 2023 | 37317053 | PubTator, text mining | PubMed |
| METTL14 is decreased and regulates m6 A modification of α-synuclein in Parkinson's disease. | J Neurochem | 2023 | 37309980 | PubTator, text mining | PubMed |
| HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis. | J Transl Med | 2023 | 37308993 | PubTator, text mining | PubMed |
| N6-methyladenosine is required for efficient RNA synthesis of Ebola virus and other haemorrhagic fever viruses. | Emerg Microbes Infect | 2023 | 37306620 | PubTator, text mining | PubMed |
| Genome-wide detection of m6A-associated SNPs in atrial fibrillation pathogenesis. | Front Cardiovasc Med | 2023 | 37304952 | PubTator, text mining | PubMed |
| A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. | Transl Cancer Res | 2023 | 37304536 | PubTator, text mining | PubMed |
| Targeting IGF2BP3 in Cancer. | Int J Mol Sci | 2023 | 37298373 | PubTator, text mining | PubMed |
| The Emerging, Multifaceted Role of WTAP in Cancer and Cancer Therapeutics. | Cancers (Basel) | 2023 | 37297015 | PubTator, text mining | PubMed |
| PiRNA Obtained through Liquid Biopsy as a Possible Cancer Biomarker. | Diagnostics (Basel) | 2023 | 37296747 | PubTator, text mining | PubMed |
| Targeted Profiling of Epitranscriptomic Reader, Writer, and Eraser Proteins Regulated by H3K36me3. | Anal Chem | 2023 | 37296074 | PubTator, text mining | PubMed |
| The emerging roles and mechanism of N6-methyladenosine (m6A) modifications in urologic tumours progression. | Front Pharmacol | 2023 | 37284313 | PubTator, text mining | PubMed |
| The Role of RNA Methylation Modification Related Genes in Prognosis and Immunotherapy of Colorectal Cancer. | Int J Gen Med | 2023 | 37284034 | PubTator, text mining | PubMed |
| METTL14 suppresses cancer stem cell phenotype of colorectal cancer via regulating of β-catenin/NANOG. | J Cancer | 2023 | 37283789 | PubTator, text mining | PubMed |
| Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. | Biomark Res | 2023 | 37280679 | PubTator, text mining | PubMed |
| Increased METTL3 expression and m6A RNA methylation may contribute to the development of dry eye in primary Sjögren's syndrome. | BMC Ophthalmol | 2023 | 37277716 | PubTator, text mining | PubMed |
Underexplored reciprocity between genome-wide methylation status and long non-coding RNA expression reflected in breast cancer research: potential impacts for the disease management in the framework of 3P medicine. | EPMA J | 2023 | 37275549 | PubTator, text mining | PubMed |
| Mettl3 Mediated m6A Methylation Involved in Epithelial-Mesenchymal Transition by Targeting SOCS3/STAT3/SNAI1 in Cigarette Smoking-Induced COPD. | Int J Chron Obstruct Pulmon Dis | 2023 | 37275442 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57721/papers?page=55